# Fosmidomycin With Clindamycin or With Clindamycin Plus Artesunate

> **NCT01002183** · PHASE2 · WITHDRAWN · sponsor: **Jomaa Pharma GmbH** · enrollment: 40 (estimated)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Fosmidomycin

## Key facts

- **NCT ID:** NCT01002183
- **Lead sponsor:** Jomaa Pharma GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 40 (ESTIMATED)
- **Why stopped:** Drug combination is no longer pursued
- **Last updated:** 2011-09-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01002183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01002183, "Fosmidomycin With Clindamycin or With Clindamycin Plus Artesunate". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01002183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*